申请人:Abbott Laboratories
公开号:US04234594A1
公开(公告)日:1980-11-18
Described is a method of treating hypertensive by administering to mammalian patients compounds of the formula ##STR1## wherein R.sub.1 and R.sub.2 are hydrogen, loweralkyl, lowercycloalkyl, aralkyl, aryl, pyridyl, isoquinolyl, phthalazinyl, or aryl substituted by one or more hydrogen, halo, loweralkyl, lowercycloalkyl, haloloweralkyl, haloloweralkyl, aminosulfonyl, nitro, hydroxy, alkoxy, carboxy, alkoxycarbonyl, cycloalkoxy carbonyl, aminocarbonyl, diloweralkylaminocarbonyl or ##STR2## wherein n is 4 or 5. R.sub.3 is hydrogen, halogen, loweralkyl or aryl, and R.sub.4 is hydrogen, acyl, amino or loweralkyl, and the pharmaceutically acceptable acid addition salts thereof.
描述了一种治疗高血压的方法,通过向哺乳动物患者施用以下化合物的方式:其中R.sub.1和R.sub.2为氢、较低烷基、较低环烷基、芳基烷基、芳基、吡啶基、异喹啉基、菲唑啉基、或被一个或多个氢、卤素、较低烷基、较低环烷基、卤代较低烷基、氨基磺酰基、硝基、羟基、烷氧基、羧基、烷氧羰基、环烷氧羰基、氨基羰基、二较低烷基氨基羰基或其中n为4或5的芳基取代的芳基;R.sub.3为氢、卤素、较低烷基或芳基;R.sub.4为氢、酰基、氨基或较低烷基,以及其药用可接受的酸盐。